SCOPE AND SIGNIFICANCE
Eicosanoids are inflammatory lipid mediators that have been implicated in a variety of diseases such as neoplasms, inflammatory disease, and wound healing. They serve an important role in modulating the inflammatory response, but they also directly interact with keratinocytes. Keratinocyte migration and re-epithelialization is one of the important initial steps in wound healing. In this study, we review the interaction between eicosanoids and keratinocyte as it pertains to wound repair.
TRANSLATIONAL RELEVANCE
Research within wound healing depends heavily on translational models that encompass both cell culture and animal-based models. These serve as important preclinical steps to help identify signaling pathways and mechanisms before development of therapeutic strategies. In this study, the influence of eicosanoids in keratinocyte biology is reviewed with comparative discussion of the COX-1/COX-2 pathways and the 5-LOX pathway in the synthesis of eicosanoids. In doing so, the current state of knowledge is discussed and, more importantly, knowledge gaps are identified to stimulate further research.
CLINICAL RELEVANCE
Modulation of the eicosanoid pathway is clinically important. Several medications that modulate this pathway are already approved by the Food and Drug Administration for clinical use. This article overviews the importance of eicosanoids in wound healing, particularly in relation to reepithelialization. As such, it is hoped that the information presented here will stimulate clinical investigation of adapting existing drugs in novel ways for wound therapy. Modulators of eicosanoid synthesis may serve a promising and novel role in the clinical therapy of wounds.
OVERVIEW OF EICOSANOIDS
Eicosanoids represent a family of lipids derived from arachidonic acid (AA) that are biologically active mediators. AA is released from the cell membrane through activation of phospholipases due to various stimuli. AA is subsequently metabolized through three enzyme pathways to generate eicosanoids due to cyclooxygenase (COX), leukotrienes and hydroxyeicosatetraenoic acids (HETEs) due to lipoxygenase (LOX), or HETEs and epoxyeicosatrienoic acids through the cytochrome P450-dependant epoxidases. Figure 1 depicts a broad schematic for eicosanoid synthesis through the COX and LOX pathways.
The prostanoids are generated through the action of the COX enzymes. There are two forms of cyclooxygenases, COX-1 and COX-2. 1 The family of bioactive prostanoids include prostaglandins (PGD2, PGE2, and PGF2a), prostacylin (PGI2), and thromboxane A2. 2 The prostanoid receptors were pharmacologically characterized based on their ability to bind PDG2, PGE2, PGF2a, PGI2, and thromboxane A2 as DP, EP, FP, IP, and TP receptors, respectively. 2 The DP receptors are subdivided into DP1 and DP2 and the EP receptors are subdivided into EP1, EP2, EP3, and EP4.
2 These receptors are G-protein-coupled transmembrane receptors that signal through various pathways, including cAMP, ERK, and AKT. 2 Keratinocytes express both COX-1 and COX-2, with COX-2 primarily found in the suprabasilar keratinocytes, 2 and have the ability to synthesize multiple prostanoids. 3 Keratinocytes express multiple prostanoid receptors, such as EP1, 4 EP2, 4,5 EP3, 5 and low levels of EP4 (based on mRNA expression). 5 The LOX enzymes are structurally related dioxygenases involved in the production of fatty acid hydroperoxides by acting on polyunsaturated fatty acids. 6 Humans express multiple LOXs in the skin. 7 The nomenclature is based on the specificity of action for each enzyme in the family. 8 For example, 5-LOX oxygenates AA at carbon-5 and 12-LOX at the carbon-12 position.
The leukotrienes are a subfamily of lipid mediators that are generated through the action of 5-LOX on AA. 9 Leukotriene A4 (LTA4) is the first product of 5-LOX and this leads to the generation of LTB4, LTC4, LTD4, and LTE4. 9 There are multiple leukotriene receptors, including the LTB4 receptor type-1 (BLT1), BLT2, and the CysLT family of receptors that act as G-protein-coupled transmembrane receptors. 9 Murine keratinocytes have been shown to produce LTB4. 10 However, studies in human keratinocytes remain mixed with one study that showed a lack of expression of 5-LOX or the ability for endogenous LTB4 production, 11 while others noted expression of 5-LOX in the epidermis 12 and documented LTB4 13 and 5-HETE release. 13 Regardless, keratinocytes can produce LTB4 in the presence of LTA4 as they express the LTA4 hydrolase necessary for the synthesis of LTB4.
14 Keratinocytes express the BLT1 15 and BLT2 16 leukotriene-sensitive receptors. Eicosanoids play an important role in wound healing (Fig. 2) . Keratinocytes are capable of both producing and responding to eicosanoids in the wound. Figure 1 . Schematic of the major eicosanoid synthesis pathways that involve the lipoxgenase (LOX) and cyclooxygenase (COX) pathways. LTA4, leukotrienes A4; LTB4, leukotriene B4; HETE, hydroxyeicosatetraenoic acid; PGG2, prostaglandin G2; PGH2, prostaglandin H2; PGI2, prostacyclin; PGD2, prostaglandin D2; PGE2, prostaglandin E2; PGF2a, prostaglandin F2a; TXA2, thromboxane A2.
DISCUSSION Eicosanoids in the wound microenvironment
Eicosanoids are abundant in the wound bed early after tissue injury. 17 Multiple cells typically found in the wound bed are capable of eicosanoid synthesis. 3, 8, 18, 19 Bacteria can induce synthesis of various eicosanoids, 20 although their contribution in acute and chronic wounds remains to be further studied. Free radical-induced conversion of AA into the isoprostanes, 21 which serve as prostaglandin analogs, augments the eicosanoid levels in the wound.
Prostanoids
Keratinocyte proliferation. Prostanoids increase the proliferation of epithelial cells (Table 1) through both direct and indirect mechanisms. PGE1 and PGI1 analogues increase keratinocyte proliferation, 22, 23 as does PGE2. 5 Furthermore, the stimulation of keratinocyte EP2 and EP4 receptors promotes keratinocyte proliferation.
5
PGE1 can stimulate keratinocyte proliferation indirectly as well. PGE1 can induce IL-6 production in fibroblasts, which can in turn stimulate keratinocyte proliferation. 23 Keratinocyte migration. Several studies have examined the role of prostanoids in keratinocyte migration (Table 1 ). In mice, COX-2 expression was found to increase in the hyperplastic keratinocytes at the edge of an incisional wound 24 and in keratinocytes migrating from the edge of an incisional wound. 25 COX-2 expression also increased in underlying keratinocytes in an abrasion injury model where he superficial stratum corneum was removed without direct injury to the underlying epidermis. 26 The results on the effects of pharmacological inhibition of COX-2 are mixed in mouse incisional wounds in vivo with one study showing an early transient decrease in reepithelialization, 24 while another study showed increased re-epithelialization. 27 Furthermore, two other studies did not note any effects on skin wound healing, 28, 29 and yet another study demonstrated reduced tensile strength in mice with either COX-1 or COX-2 genes knocked out. 30 None of these studies specifically evaluated keratinocyte re-epithelialization. It is unclear how well incisional wounds and unsplinted excisional wounds in mice mimic human wounds, since wounds in mice involve significant contraction, while human wounds rely heavily on reepithelialization and granulation tissue formation. 31 Taken together, COX-2 is upregulated in keratinocytes adjacent to a wound and prostanoids increase their proliferation. However, their role in re-epithelialization and keratinocyte migration remains unclear. Future studies in wounds that more closely replicate human wounds, such as porcine models and ex vivo human skin models, are needed to better identify the influence of COX-2-derived products on keratinocyte migration.
LOX products
Keratinocyte proliferation. Few studies have evaluated the association between leukotrienes and keratinocyte proliferation. Multiple leukotrienes have been shown to increase DNA synthesis rates in cultured human keratinocytes. 32 Topical Figure 2 . Eicosanoids modulate keratinocyte proliferation and migration, as well as stratum corneum barrier formation. application of LTB4 induced hyperproliferation in humans when applied to psoriatic skin, but not in uninvolved skin. 33 Yet, the use of a 5-LOX inhibitor did not alter keratinocyte proliferation 34 in cell culture nor was it noted to reduce epidermal proliferation when given orally to patients with psoriasis. 35 Therefore, while leukotrienes may be capable of increasing proliferation, the inhibition of their effects may not be sufficient to reduce keratinocyte proliferation. Further studies that specifically evaluate the role of leukotrienes and its inhibitors are needed to better delineate their effects on keratinocyte proliferation.
Keratinocyte migration. In murine keratinocytes, activation of the BTL2 receptor increased ERK phosphorylation and induced their migration, 36 but similar studies in human keratinocytes are lacking. Keratinocytes have been shown to increase the expression of matrix metalloproteinase-1 (MMP-1) in response to stimulation of the LTB4-sensitive BLT2. 16 Upregulation of MMP-1 has been associated with a migratory phenotype in keratinocytes, 37 but the direct effect of BLT2 receptor activation on human keratinocyte migration has not been evaluated. Studies in 5-LOX-deficient mice showed accelerated wound healing, but the reepithelialization rates did not appear to differ between the 5-LOX and wild-type mice. 38 It is not clear whether prostanoid levels were elevated in the 5-LOX knockout mice in light of other studies that have shown shunting from the 5-LOX pathway into the COX-1/COX-2 pathway with 5-LOX inhibition. 39 Regardless, the lack of 5-LOX activity was not a detriment against wound re-epithelialization. 12-HETE is produced in the epidermis and is bound by keratinocytes 40 and appears to stimulate keratinocyte chemotaxis toward it. 41 Taken together, leukotrienes may increase murine keratinocyte migration, but its role in human keratinocytes remains unstudied. The role of HETEs in keratinocyte migration needs further elucidation as well.
Barrier formation
An important step in wound repair after reepithelialization is the formation of a mature epidermal barrier. This depends on the terminal differentiation of keratinocytes and the eventual formation of a mature stratum corneum. The eicosanoids have an important role in the formation of the epidermal barrier ( Table 1) .
The prostanoids accelerate recovery of the epidermal barrier. 42, 43 Indomethacin, a nonselective inhibitor of COX-1 and COX-2, decreased transepidermal water loss (TEWL) recovery after mechanical disruption of the barrier in mice. 42 Selective inhibition of COX-1 and COX-2 suggested that COX-1-modulated PGD2 was important for barrier recovery. 44 PGD2 was shown to accelerate barrier recovery in mice after mechanical disruption of the stratum corneum based on the recovery of the TEWL. 42, 45 Studies on PGE2 were mixed with one study showing no effect 42 and another showing improvement of the barrier function. 45 Future studies with disruption of the human skin barrier, perhaps through tape stripping, would help evaluate if the findings in mice extend to humans.
The lipooxygenases are important in the development of the skin barrier. In particular, 12-LOX and epidermal lipoxygenase-3 (eLOX3) are important for ceramide synthesis and mature barrier formation. 46 This is confirmed by the disrupted barrier in both 12R-LOX-deficient 47, 48 and eLOX3-deficient 49 mice. Consistent with the implication that LOX enzymes are important for maintaining epidermal homeostasis, mutations in the genes for eLOX-3 and 12R-LOX have been associated with autosomal recessive, nonbullous congenital ichthyosiform erythroderma in humans. 50 
SUMMARY
Eicosanoids play an important role in modulating keratinocyte biology. This lipid family has functions that are plastic and move beyond serving as inflammatory mediators. The current state of knowledge is building with a better understanding of how the prostanoids, leukotrienes, and the LOX products interact with the keratinocytes in the wound microenvironment. Further research is needed in human cells and human tissue and the modulation of eicosanoid synthesis is promising for further investigation.
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